1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Crizotinib
1.2.3 Alectinib
1.2.4 Ceritinib
1.2.5 Brigatinib
1.2.6 Other
1.3 Market by Application
1.3.1 Global ALK Positive Lung Cancer Treatment Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global ALK Positive Lung Cancer Treatment Market Perspective (2017-2028)
2.2 ALK Positive Lung Cancer Treatment Growth Trends by Region
2.2.1 ALK Positive Lung Cancer Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 ALK Positive Lung Cancer Treatment Historic Market Size by Region (2017-2022)
2.2.3 ALK Positive Lung Cancer Treatment Forecasted Market Size by Region (2023-2028)
2.3 ALK Positive Lung Cancer Treatment Market Dynamics
2.3.1 ALK Positive Lung Cancer Treatment Industry Trends
2.3.2 ALK Positive Lung Cancer Treatment Market Drivers
2.3.3 ALK Positive Lung Cancer Treatment Market Challenges
2.3.4 ALK Positive Lung Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top ALK Positive Lung Cancer Treatment Players by Revenue
3.1.1 Global Top ALK Positive Lung Cancer Treatment Players by Revenue (2017-2022)
3.1.2 Global ALK Positive Lung Cancer Treatment Revenue Market Share by Players (2017-2022)
3.2 Global ALK Positive Lung Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by ALK Positive Lung Cancer Treatment Revenue
3.4 Global ALK Positive Lung Cancer Treatment Market Concentration Ratio
3.4.1 Global ALK Positive Lung Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by ALK Positive Lung Cancer Treatment Revenue in 2021
3.5 ALK Positive Lung Cancer Treatment Key Players Head office and Area Served
3.6 Key Players ALK Positive Lung Cancer Treatment Product Solution and Service
3.7 Date of Enter into ALK Positive Lung Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 ALK Positive Lung Cancer Treatment Breakdown Data by Type
4.1 Global ALK Positive Lung Cancer Treatment Historic Market Size by Type (2017-2022)
4.2 Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Type (2023-2028)
5 ALK Positive Lung Cancer Treatment Breakdown Data by Application
5.1 Global ALK Positive Lung Cancer Treatment Historic Market Size by Application (2017-2022)
5.2 Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America ALK Positive Lung Cancer Treatment Market Size (2017-2028)
6.2 North America ALK Positive Lung Cancer Treatment Market Size by Country (2017-2022)
6.3 North America ALK Positive Lung Cancer Treatment Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe ALK Positive Lung Cancer Treatment Market Size (2017-2028)
7.2 Europe ALK Positive Lung Cancer Treatment Market Size by Country (2017-2022)
7.3 Europe ALK Positive Lung Cancer Treatment Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size (2017-2028)
8.2 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Country (2017-2022)
8.3 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America ALK Positive Lung Cancer Treatment Market Size (2017-2028)
9.2 Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2017-2022)
9.3 Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size (2017-2028)
10.2 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country (2017-2022)
10.3 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Detail
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche ALK Positive Lung Cancer Treatment Introduction
11.1.4 F. Hoffmann-La Roche Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer ALK Positive Lung Cancer Treatment Introduction
11.2.4 Pfizer Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
11.2.5 Pfizer Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis ALK Positive Lung Cancer Treatment Introduction
11.3.4 Novartis Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
11.3.5 Novartis Recent Development
11.4 TP Therapeutics
11.4.1 TP Therapeutics Company Detail
11.4.2 TP Therapeutics Business Overview
11.4.3 TP Therapeutics ALK Positive Lung Cancer Treatment Introduction
11.4.4 TP Therapeutics Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
11.4.5 TP Therapeutics Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Detail
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb ALK Positive Lung Cancer Treatment Introduction
11.5.4 Bristol-Myers Squibb Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Company Detail
11.6.2 Eli Lilly and Company Business Overview
11.6.3 Eli Lilly and Company ALK Positive Lung Cancer Treatment Introduction
11.6.4 Eli Lilly and Company Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
11.6.5 Eli Lilly and Company Recent Development
11.7 Takeda
11.7.1 Takeda Company Detail
11.7.2 Takeda Business Overview
11.7.3 Takeda ALK Positive Lung Cancer Treatment Introduction
11.7.4 Takeda Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
11.7.5 Takeda Recent Development
11.8 Beacon Pharma
11.8.1 Beacon Pharma Company Detail
11.8.2 Beacon Pharma Business Overview
11.8.3 Beacon Pharma ALK Positive Lung Cancer Treatment Introduction
11.8.4 Beacon Pharma Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
11.8.5 Beacon Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
